SLN for topical application in skin diseases-Characterization of drug-carrier and carrier-target interactions

International Journal of Pharmaceutics

Volumn 390, Issue 2, 2010, Pages 225-233

  Küchler, Sarah ^a   Herrmann, Werner ^a   Panek Minkin, Grazyna ^a   Blaschke, Tobias ^a   Zoschke, Christian ^a   Kramer, Klaus D ^a   Bittl, Robert ^a   Schäfer Korting, Monika ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Carrier target interaction; Drug carrier interaction; Electron spin resonance; Skin penetration; Solid lipid nanoparticles; Spin probes

Indexed keywords

2,2,6,6 TETRAMETHYL 4 TRIMETHYLAMMONIUMPIPERIDIN 1 OXYL IODIDE; 2,2,6,6 TETRAMETHYLPIPERIDIN 1 OXYL; DRUG CARRIER; PIPERIDINE DERIVATIVE; SKIN LIPID; SOLID LIPID NANOPARTICLE; SURFACTANT; TEMPOL; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; DRUG UPTAKE; ELECTRON SPIN RESONANCE; LIPOPHILICITY; LOADING TEST; MOLECULAR INTERACTION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS MODEL; SKIN DISEASE; SPECTROSCOPY; SPIN LABELING;

ADMINISTRATION, CUTANEOUS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; LIPIDS; NANOPARTICLES; PARTICLE SIZE; SKIN ABSORPTION; SKIN DISEASES; SPIN LABELS;

EID: 77951499085     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.02.004     Document Type: Article

References (30)

1. Ahlin P., Kristl J., Sentjurc M., Strancar J., Pecar S. Influence of spin probe structure on its distribution in SLN dispersions. Int. J. Pharm. 2000, 196:241-244.
2. Blaschke T., Kankate L., Kramer K.D. Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy. Adv. Drug Deliv. Rev. 2007, 59:403-410.
3. Braem C., Blaschke T., Panek-Minkin G., Herrmann W., Schlupp P., Paepenmüller T., Müller-Goyman C., Mehnert W., Bittl R., Schäfer-Korting M., Kramer K.D. Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. J. Control. Release 2007, 119:128-135.
4. Budil D.E., Lee S., Saxena S., Freed J. Nonlinear-least-squares analysis of slow-motion EPR spectra in one or two dimensions using a modified Levenberg-Marquardt algorithm. J. Magn. Res. 1996, A 120:155-189.
5. Chen H., Chang X., Du D., Liu W., Liu J., Weng T., Yang Y., Xu H., Yang X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Release 2006, 110:296-306.
6. Degim T., Hadgraft J., Ilbasmis S., Ozkan Y. Prediction of skin penetration using artificial neural network (ANN) modeling. J. Pharm. Sci. 2003, 92:656-664.
7. Herrmann W., Stosser R., Borchert H.H. ESR imaging investigations of two-phase systems. Magn. Reson. Chem. 2007, 45:496-507.
8. Jaeckle E., Schaefer U.F., Loth H. Comparison of effects of different ointment bases on the penetration of ketoprofen through heat-separated human epidermis and artificial lipid barriers. J. Pharm. Sci. 2003, 92:1396-1406.
9. Jenning V., Gysler A., Schäfer-Korting M., Gohla S.H. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 2000, 49:211-218.
10. Jenning V., Schäfer-Korting M., Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control. Release 2000, 66:115-126.
11. Jores K., Mehnert W., Mader K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharm. Res. 2003, 20:1274-1283.
12. Kalariya M., Padhi B.K., Chougule M., Misra A. Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications. Indian J. Exp. Biol. 2005, 43:233-240.
13. Küchler S., Adbel-Mottaleb M., Lamprecht A., Radowski M.R., Haag R., Schäfer-Korting M. Influences of nanocarriers' type and size on skin delivery of hydrophilic agents. Int. J. Pharm. 2009, 10.1016/j.ijpharm.2009.04.046.
14. Küchler S., Radowski M.R., Blaschke T., Dathe M., Plendl J., Haag R., Schäfer-Korting M., Kramer K.D. Nanoparticles for skin penetration enhancement-a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 2009, 71:243-250.
15. Kuntsche J., Bunjes H., Fahr A., Pappinen S., Ronkko S., Suhonen M., Urtti A. Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model. Int. J. Pharm. 2008, 354:180-195.
16. Lamprecht A., Saulnier P., Boury F., Passirani C., Proust J.E., Benoit J.P. A quantitative method for the determination of amphiphilic drug release kinetics from nanoparticles using a Langmuir balance. Anal. Chem. 2002, 74:3416-3420.
17. Lombardi Borgia S., Regehly M., Sivaramakrishnan R., Mehnert W., Korting H.C., Danker K., Röder B., Kramer K.D., Schäfer-Korting M. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Release 2005, 110:151-163.
18. Manjunath K., Reddy J.S., Venkateswarlu V. Solid lipid nanoparticles as drug delivery systems. Methods Find. Exp. Clin. Pharmacol. 2005, 27:127-144.
19. Moll K.P., Herrmann W., Stosser R., Borchert H.H. Changes of the properties in the upper layers of human skin on treatment with models of different pharmaceutical formulations-an ex vivo ESR imaging study. ChemMedChem 2008, 3:653-659.
20. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50:161-177.
21. Müller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002, 54(Suppl. 1):S131-155.
22. Münster U., Nakamura C., Haberland A., Jores K., Mehnert W., Rummel S., Schaller M., Korting H.C., Zouboulis Ch C., Blume-Peytavi U., Schäfer-Korting M. RU 58841-myristate-prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie 2005, 60:8-12.
23. Musial W., Kubis A. Preliminary assessment of alginic acid as a factor buffering triethanolamine interacting with artificial skin sebum. Eur. J. Pharm. Biopharm. 2003, 55:237-240.
24. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 1992, 9:663-669.
25. Santos Maia C., Mehnert W., Schaller M., Korting H.C., Gysler A., Haberland A., Schäfer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target. 2002, 10:489-495.
26. Schäfer-Korting M., Bock U., Diembeck W., Düsing H.J., Gamer A., Haltner-Ukomadu E., Hoffmann C., Kaca M., Kamp H., Kersen S., Kietzmann M., Korting H.C., Krächter H.U., Lehr C.M., Liebsch M., Mehling A., Müller-Goymann C., Netzlaff F., Niedorf F., Rübbelke M.K., Schäfer U., Schmidt E., Schreiber S., Spielmann H., Vuia A., Weimer M. The use of reconstructed human epidermis for skin absorption testing: results of the validation study. Altern. Lab Anim. 2008, 36:161-187.
27. Schäfer-Korting M., Mehnert W., Korting H.C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 2007, 59:427-443.
28. Sivaramakrishnan R., Nakamura C., Mehnert W., Korting H.C., Kramer K.D., Schäfer-Korting M. Glucocorticoid entrapment into lipid carriers-characterisation by parelectric spectroscopy and influence on dermal uptake. J. Control. Release 2004, 97:493-502.
29. Stecova J., Mehnert W., Blaschke T., Kleuser B., Sivaramakrishnan R., Zouboulis C.C., Seltmann H., Korting H.C., Kramer K.D., Schäfer-Korting M. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm. Res. 2007, 24:991-1000.
30. zur Mühlen A., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Biopharm. 1998, 45:149-155.